chevron_leftBack
As of 24 April 2025, CeriBell, Inc. has a market cap of $540.89M USD, ranking #11484 globally and #2238 in the United States. It ranks #1116 in the Healthcare sector, and #119 in the Medical Devices industry.
Key Stats
Market Cap
$540.89MUSD
Enterprise Value
$368.48MUSD
Revenue (TTM)
$65.44MUSD
EBITDA (TTM)
-$38.57MUSD
Net Income (TTM)
-$40.46MUSD
EBITDA Margin
-59%
Profit Margin
-62%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Xingjuan Chao
open_in_new
Employees
281
Founded
2014
IPO
11 Oct 2024
Website
ceribell.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2% | 4% | -26% | -35% | -43% | -35% |
Upcoming Earnings
Earnings Date
Wed, May 14
Earnings Time
sunny
Before Open
EPS Estimate
-$0.4600
Revenue Estimate
$19.3M
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CBLL
CeriBell Inc
ISIN: US15678C1027
Shares Out.:
Shares Outstanding:
35.868M1
Shares Float:
20.852M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
15.07 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
